Danaher (DHR) Total Non-Current Liabilities (2009 - 2026)
Danaher (DHR) recorded quarterly Total Non-Current Liabilities of $25.0 billion in Q1 2026, down 0.8% quarter-over-quarter from $25.2 billion in Q4 2025, and up 10.64% on a YoY basis from $22.6 billion in Q1 2025.
Danaher (DHR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Danaher's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $25.0 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 10.64% year-over-year to $25.0 billion; the TTM figure through Mar 2026 stood at $25.0 billion (up 10.64% YoY), while the FY2025 annual figure was $25.2 billion, down 65.03% from the prior year.
- Total Non-Current Liabilities was $25.0 billion for Q1 2026 at Danaher, down from $25.2 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $82.0 billion in Q2 2023 to a low of $22.6 billion in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $51.2 billion across 5 years, with a median of $59.0 billion in 2025.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities jumped 188.81% in 2024, then plunged 70.86% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $77.8 billion in 2022, then slumped by 67.91% to $25.0 billion in 2023, then surged by 188.81% to $72.1 billion in 2024, then plunged by 65.03% to $25.2 billion in 2025, then declined by 0.8% to $25.0 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $25.0 billion (Q1 2026), $25.2 billion (Q4 2025), and $23.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 22.71 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 737.18 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | 8.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 27, 2026 | 25.03 Bn |
| Dec 31, 2025 | 25.23 Bn |
| Sep 26, 2025 | 23.17 Bn |
| Jun 27, 2025 | 59.03 Bn |
| Mar 28, 2025 | 22.62 Bn |
| Dec 31, 2024 | 72.15 Bn |
| Sep 27, 2024 | 23.66 Bn |
| Jun 28, 2024 | 75.19 Bn |
| Mar 29, 2024 | 77.63 Bn |
| Dec 31, 2023 | 24.98 Bn |
| Sep 29, 2023 | 28.88 Bn |
| Jun 30, 2023 | 81.99 Bn |
| Mar 31, 2023 | 78.47 Bn |
| Dec 31, 2022 | 77.84 Bn |
| Sep 30, 2022 | 26.54 Bn |
| Jul 1, 2022 | 72.54 Bn |
| Apr 1, 2022 | 75.67 Bn |
| Dec 31, 2021 | 42.66 Bn |
| Oct 1, 2021 | 30.85 Bn |
| Jul 2, 2021 | 39.73 Bn |